To beta-amyloid or not to beta-amyloid? An innovative meta-analysis offers new insight into Alzheimer’s drugs

To beta-amyloid or not to beta-amyloid? An innovative meta-analysis offers new insight into Alzheimer’s drugs – UCSF Department of Epidemiology & Biostatistics

Original study: Effect of reductions in amyloid levels on cognitive change in randomized trials: instrumental variable meta-analysis – The BMJ

See also: Instrumental variable meta-analysis of aggregated randomized drug trial data for evaluating proposed target mechanisms – The BMJ

Commentary on Twitter

https://twitter.com/artwalaszek/status/1365098101845987328